Novartis Entresto One Step Closer To European Commission Approval
Novartis ($NVS) has recently suggested that its kick off of recently US FDA accepted heart failure medicine Entresto will be
Read moreNovartis ($NVS) has recently suggested that its kick off of recently US FDA accepted heart failure medicine Entresto will be
Read moreSwitzerland based leading global pharmaceutical company Novartis has obtained approval from the US Food and Drug Administration (FDA) for its
Read moreA clinical trail on a promising therapy for Type 1 diabetes designed by a Ben-Gurion University of the Negev (BGU)
Read moreEarlier on Thursday, Drugmakers Boehringer Ingelheim and Eli Lilly and Co. announced that their type 2 diabetes treatment Trajenta has
Read more